{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:04:43Z","timestamp":1773291883085,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2000,11]]},"DOI":"10.1378\/chest.118.5.1470","type":"journal-article","created":{"date-parts":[[2003,6,14]],"date-time":"2003-06-14T00:09:19Z","timestamp":1055549359000},"page":"1470-1476","source":"Crossref","is-referenced-by-count":140,"title":["Aspirin and Asthma"],"prefix":"10.1016","volume":"118","author":[{"given":"K. Suresh","family":"Babu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sundeep S.","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.118.5.1470_bib1","first-page":"189","article-title":"Anaphylaxie et idiosyncrasie","volume":"30","author":"Widal","year":"1922","journal-title":"Presse Med"},{"key":"10.1378\/chest.118.5.1470_bib2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0091-6749(79)90059-9","article-title":"Aspirin and concomitant idiosyncrasies in adult asthmatic patients","volume":"64","author":"Spector","year":"1979","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.118.5.1470_bib3","first-page":"84","article-title":"NSAID-induced bronchospasm: a common and serious problem; a report from MEDSAFE, the New Zealand medicines and medical devices safety authority","volume":"95","author":"Sturtevant","year":"1999","journal-title":"NZ Dent J"},{"key":"10.1378\/chest.118.5.1470_bib4","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ije\/28.4.717","article-title":"Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study","volume":"28","author":"Hedman","year":"1999","journal-title":"Int J Epidemiol"},{"key":"10.1378\/chest.118.5.1470_bib5","series-title":"Involvement of drugs and chemicals","first-page":"125","article-title":"Drug-induced pseudo-allergic syndrome as exemplified by acetyl salicylic acid intolerance","author":"Schlumberger","year":"1980"},{"key":"10.1378\/chest.118.5.1470_bib6","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/ajrccm\/144.4.957","article-title":"The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma","volume":"144","author":"Christie","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.118.5.1470_bib7","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1164\/ajrccm\/146.6.1531","article-title":"Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects","volume":"146","author":"Christie","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.118.5.1470_bib8","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1164\/ajrccm.149.4.8143059","article-title":"Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge","volume":"149","author":"Sladek","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.118.5.1470_bib9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1172\/JCI620","article-title":"Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma","volume":"101","author":"Cowburn","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.118.5.1470_bib10","doi-asserted-by":"crossref","first-page":"11356","DOI":"10.1074\/jbc.271.19.11356","article-title":"Molecular cloning of the gene for human leukotriene C4 synthase: organization, nucleotide sequence, and chromosomal localization to 5q35","volume":"271","author":"Penrose","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1378\/chest.118.5.1470_bib11","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0140-6736(05)64015-9","article-title":"Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma","volume":"350","author":"Sanak","year":"1997","journal-title":"Lancet"},{"key":"10.1378\/chest.118.5.1470_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0091-6749(99)70106-5","article-title":"Aspirin-induced asthma: advances in pathogenesis and management","volume":"104","author":"Szczeklik","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.118.5.1470_bib13","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1172\/JCI119241","article-title":"Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription","volume":"99","author":"In","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.118.5.1470_bib14","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.4049\/jimmunol.133.4.2138","article-title":"Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release","volume":"133","author":"Holgate","year":"1984","journal-title":"J Immunol"},{"key":"10.1378\/chest.118.5.1470_bib15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1164\/ajrccm\/140.2.449","article-title":"Cyclooxygenase metabolism of endogenous arachidonic acid by cultured human tracheal epithelial cells","volume":"140","author":"Churchill","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.118.5.1470_bib16","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/thx.52.11.940","article-title":"Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma","volume":"52","author":"Sousa","year":"1997","journal-title":"Thorax"},{"key":"10.1378\/chest.118.5.1470_bib17","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1164\/ajrccm.154.6.8970343","article-title":"Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics","volume":"154","author":"Szczeklik","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.118.5.1470_bib18","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/thx.52.11.933","article-title":"Too many COX (cyclo-oxygenase) spoil the broth: aspirin-sensitive asthma and 5-lypoxygenase","volume":"52","author":"Mitchell","year":"1997","journal-title":"Thorax"},{"key":"10.1378\/chest.118.5.1470_bib19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1164\/ajrccm.153.1.8542168","article-title":"Inflammatory cell populations in bronchial biopsies from aspirin- sensitive asthmatic subjects","volume":"153","author":"Nasser","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.118.5.1470_bib20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0889-8561(22)00270-3","article-title":"The role of lung mononuclear cells in asthma, allergy and bronchial hyperresponsiveness","volume":"10","author":"Martin","year":"1990","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1378\/chest.118.5.1470_bib21","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/ajrccm.156.5.9702072","article-title":"Expression of interleukin-5 and granulocyte-macrophage colony- stimulating factor in aspirin-sensitive and non-aspirin-sensitive asthmatic airways","volume":"156","author":"Sousa","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.118.5.1470_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2222.1988.tb02838.x","article-title":"Aspirin-induced asthma as a viral disease","volume":"18","author":"Szczeklik","year":"1988","journal-title":"Clin Allergy"},{"key":"10.1378\/chest.118.5.1470_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002018-199716010-00001","article-title":"Role of viral infections in the induction of adverse drug reactions","volume":"16","author":"Levy","year":"1997","journal-title":"Drug Saf"},{"key":"10.1378\/chest.118.5.1470_bib24","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0091-6749(98)70327-6","article-title":"Effect of acyclovir on bronchoconstriction and urinary leukotriene E4 excretion in aspirin-induced asthma","volume":"102","author":"Yoshida","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.118.5.1470_bib25","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-68-5-975","article-title":"Intolerance to aspirin: clinical studies and consideration of its pathogenesis","volume":"68","author":"Samter","year":"1968","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.118.5.1470_bib26","series-title":"Allergy principles and practice","first-page":"1747","article-title":"Sensitivity to aspirin and non-steroidal anti-inflammatory drugs","author":"Stevenson","year":"1998"},{"key":"10.1378\/chest.118.5.1470_bib27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1164\/ajrccm\/146.1.76","article-title":"Long-term prognosis of near-fatal asthma: a 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near- fatal attack of asthma","volume":"146","author":"Marquette","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.118.5.1470_bib28","first-page":"84","article-title":"Allergy to pyramidon (aminopyrine)","volume":"31","author":"Patriarca","year":"1973","journal-title":"Ann Allergy"},{"key":"10.1378\/chest.118.5.1470_bib29","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0091-6749(77)90106-3","article-title":"Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis","volume":"60","author":"Szczeklik","year":"1977","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.118.5.1470_bib30","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0091-6749(98)70163-0","article-title":"Nasal provocation test with lysine-aspirin for diagnosis of aspirin- sensitive asthma","volume":"101","author":"Milewski","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.118.5.1470_bib31","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0091-6749(95)70290-3","article-title":"Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects","volume":"96","author":"Settipane","year":"1995","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl","key":"10.1378\/chest.118.5.1470_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00003495-199300461-00024","article-title":"Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin","volume":"46","author":"Bianco","year":"1993","journal-title":"Drugs"},{"key":"10.1378\/chest.118.5.1470_bib33","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1398-9995.1998.tb03854.x","article-title":"Relative safety of meloxicam in NSAID-intolerant patients","volume":"53","author":"Kosnik","year":"1998","journal-title":"Allergy"},{"key":"10.1378\/chest.118.5.1470_bib34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/0091-6749(85)90771-7","article-title":"Hydrocortisone and airflow impairment in aspirin-induced asthma","volume":"76","author":"Szczeklik","year":"1985","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.118.5.1470_bib35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0091-6749(95)70299-7","article-title":"Hydrocortisone sodium succinate does not cross-react with aspirin in aspirin-sensitive patients with asthma","volume":"96","author":"Feigenbaum","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.118.5.1470_bib36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJM199901213400306","article-title":"Treatment of asthma with drugs modifying the leukotriene pathway","volume":"340","author":"Drazen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.118.5.1470_bib37","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1447","article-title":"The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin","volume":"148","author":"Israel","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.118.5.1470_bib38","first-page":"S229","article-title":"Effectiveness of the 5-LO inhibitor zileuton during oral challenges in aspirin-sensitive asthmatics [abstract]","volume":"103","author":"Pauls","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.118.5.1470_bib39","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1164\/ajrccm.157.4.9707089","article-title":"Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics","volume":"157","author":"Dahlen","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.118.5.1470_bib40","first-page":"A975","article-title":"Montelucast (MK-0476) a CysLT1 receptor antagonist improves asthma control in aspirin-intolerant asthmatic patients [abstract]","volume":"155","author":"Kuna","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.118.5.1470_bib41","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0091-6749(99)70459-8","article-title":"Leukotriene modifiers: new drugs, old and new reactions","volume":"103","author":"Rosenwasser","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.118.5.1470_bib42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2165\/00002018-199921040-00001","article-title":"Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?","volume":"21","author":"Wechsler","year":"1999","journal-title":"Drug Saf"},{"key":"10.1378\/chest.118.5.1470_bib43","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/ajrccm.158.4.9710043","article-title":"Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism","volume":"158","author":"Szczeklik","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.118.5.1470_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0091-6749(82)90081-1","article-title":"Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period","volume":"69","author":"Pleskow","year":"1982","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.118.5.1470_bib45","first-page":"156","article-title":"Tolerance to aspirin in aspirin-sensitive asthmatics: methods of inducing the tolerance state and its influence on the course of asthma and rhinosinusitis","volume":"3","author":"Szmidt","year":"1993","journal-title":"J Invest Allergol Clin Immunol"},{"key":"10.1378\/chest.118.5.1470_bib46","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1164\/ajrccm.151.5.7735581","article-title":"The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma","volume":"151","author":"Nasser","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.118.5.1470_bib47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0091-6749(90)90222-P","article-title":"Long-term effects of aspirin desensitization\u2013treatment for aspirin-sensitive rhinosinusitis-asthma","volume":"85","author":"Sweet","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.118.5.1470_bib48","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0091-6749(96)70123-9","article-title":"Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes","volume":"98","author":"Stevenson","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.118.5.1470_bib49","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/0140-6736(91)93185-C","article-title":"Prevention of relapse in nasal polyposis [letter]","volume":"337","author":"Patriarca","year":"1991","journal-title":"Lancet"},{"key":"10.1378\/chest.118.5.1470_bib50","first-page":"868","article-title":"Adaptive desaktivierung bei analgetika-asthma syndrom: methodik und phanomene der toleranzinduktion","volume":"39","author":"Schmitz-Schumann","year":"1985","journal-title":"Prax Klin Pneumol"},{"key":"10.1378\/chest.118.5.1470_bib51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000006871","article-title":"Aspirin sensitivity: the role for aspirin challenge and desensitization in postmyocardial infarction patients","volume":"91","author":"Schaefer","year":"1999","journal-title":"Cardiology"},{"key":"10.1378\/chest.118.5.1470_bib52","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0091-6749(95)70002-1","article-title":"Inhibition of monocyte leukotriene B4 production after aspirin desensitization","volume":"96","author":"Juergens","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.118.5.1470_bib53","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/ajrccm\/140.1.148","article-title":"Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma","volume":"140","author":"Arm","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.118.5.1470_bib54","first-page":"28","article-title":"Aspirin-induced neutrophil chemotactic activity (NCA) in patients with aspirin-sensitive urticaria after desensitization to the drug","volume":"4","author":"Grzelewska-Rzymowska","year":"1994","journal-title":"J Invest Allergol Clin Immunol"},{"key":"10.1378\/chest.118.5.1470_bib55","first-page":"51","article-title":"Asthma induced by aspirin and arachidonic acid metabolites: role of leukotrienes (third part)","volume":"41","author":"Salazar Villa","year":"1994","journal-title":"Rev Alerg Mex"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215512269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215512269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T22:10:02Z","timestamp":1734041402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215512269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,11]]}},"alternative-id":["S0012369215512269"],"URL":"https:\/\/doi.org\/10.1378\/chest.118.5.1470","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2000,11]]}}}